Protagonist Therapeutics Inc buy SVB Leerink LLC
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€95.74
Performance (%)
-2.84%
Price
04.05.26
€85.50
Summary
This prediction is currently active. With a performance of -2.84%, the BUY prediction by SVB_Leerink_LLC is trending in the wrong direction. This prediction currently runs until 19.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -1.156% | -1.156% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Leerink Partners from $107.00 to $110.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
12.09.25
12.09.25
€62.24
12.09.26
12.09.26
61.32%
04.05.26
04.05.26
